These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6543246)

  • 21. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diprenorphine as a stimulus in drug discrimination learning.
    Smurthwaite ST; Riley AL
    Pharmacol Biochem Behav; 1992 Nov; 43(3):839-46. PubMed ID: 1333085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naloxone and diprenorphine reduce responding for brain self-stimulation in a fixed-ratio schedule in rats.
    Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1988 Jan; 29(1):209-12. PubMed ID: 3353428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diprenorphine has agonist activity at opioid kappa-receptors in the myenteric plexus of the guinea-pig ileum.
    Traynor JR; Corbett AD; Kosterlitz HW
    Eur J Pharmacol; 1987 May; 137(1):85-9. PubMed ID: 3038579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs.
    Holtzman SG
    J Pharmacol Exp Ther; 1985 Apr; 233(1):80-6. PubMed ID: 4039002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.
    Goldberg SR; Morse WH; Goldberg DM
    J Pharmacol Exp Ther; 1981 Mar; 216(3):500-9. PubMed ID: 7205630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat.
    White DA; Hwang ML; Holtzman SG
    Pharmacol Biochem Behav; 2005 Jul; 81(3):451-8. PubMed ID: 15907990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethanol-opioid interaction in mice.
    Tamborska E; Kotlińska J; Langwiński R
    Pol J Pharmacol Pharm; 1984; 36(4):337-44. PubMed ID: 6098896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey.
    Locke KW; Brown DR; Holtzman SG
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1275-9. PubMed ID: 6298835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid-induced suppression of rat testicular function.
    Adams ML; Sewing B; Forman JB; Meyer ER; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):323-8. PubMed ID: 8392556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of morphine administration on rat liver metallothionein and zinc metabolism.
    Hidalgo J; Giralt M; Garvey JS; Armario A
    J Pharmacol Exp Ther; 1991 Oct; 259(1):274-8. PubMed ID: 1920119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opiate-induced turning in rats after injection into the ventral tegmental area.
    Szewczak MR; Spoerlein MT
    Pharmacol Biochem Behav; 1986 Nov; 25(5):959-65. PubMed ID: 3538063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area.
    Calenco-Choukroun G; Daugé V; Gacel G; Féger J; Roques BP
    Psychopharmacology (Berl); 1991; 103(4):493-502. PubMed ID: 1648248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extent and control of shock affects naltrexone sensitivity of stress-induced analgesia and reactivity to morphine.
    Hyson RL; Ashcraft LJ; Drugan RC; Grau JW; Maier SF
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1019-25. PubMed ID: 6294682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone pretreatment blocks acute morphine-induced sensitization to naltrexone.
    White-Gbadebo D; Holtzman S
    Psychopharmacology (Berl); 1994 Mar; 114(2):225-8. PubMed ID: 7838911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.
    Yoburn BC; Goodman RR; Cohen AH; Pasternak GW; Inturrisi CE
    Life Sci; 1985 Jun; 36(24):2325-32. PubMed ID: 2989632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diprenorphine and naloxone in squirrel monkeys with enhanced sensitivity to opioid antagonists.
    Oliveto AH; Dykstra LA
    Psychopharmacology (Berl); 1988; 95(3):339-43. PubMed ID: 3137619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.